Flora Peyvandi at Università degli Studi di Milano - Research Interests, Publications & Academic Profile

Flora Peyvandi

Università degli Studi di Torino

Italy

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Continue in dashboard

Contact this professor

ORCID

Google Scholar

Research Interests

Internal Medicine

60%

Cardiology

50%

Hemostasis

80%

Hemophilia

70%

Bleeding Disorders

60%

Blood Management

50%

Medical Science

40%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles21

Type 2M/2A von Willebrand disease: a shared phenotype between type 2M and 2A

Article Link

Year:

2024

Liver-related aspects of valoctocogene roxaparvovec gene therapy for hemophilia A: expert guidance for clinical practice

Article Link

Year:

2024

Pharmacokinetics of Efmoroctocog alfa by Two-Compartment Model Highlights Hemophilia A Patients with Biphasic Decay, Long Mean Residence Time, and Beta Half-Life

Article Link

Year:

2024

Global prevalence of hereditary thrombotic thrombocytopenic purpura determined by genetic analysis

Article Link

Year:

2024

Application of genetic testing for the diagnosis of von Willebrand disease

Article Link

Year:

2024

Gene therapy for people with hemophilia B: a proposed care delivery model in Italy

Article Link

Year:

2024

von Willebrand disease

Article Link

Year:

2024

D-dimer for patients on VKA vs DOAC: impact on the validity of D-dimer to make decision for extended anticoagulation

Article Link

Year:

2024

Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A

Article Link

Year:

2024

Transitioning from emicizumab prophylaxis to valoctocogene roxaparvovec gene therapy: A simulation study for individuals with severe haemophilia A

Article Link

Year:

2024

Administration of gene therapy for haemophilia – The hub and spoke model and its regional differences and challenges

Article Link

Year:

2024

Prophylaxis with recombinant von Willebrand factor in patients with type 3 von Willebrand disease: Results of a post hoc analysis from a phase 3 trial

Article Link

Year:

2023

Nailfold Videocapillaroscopic Alterations as Markers of Microangiopathy in COVID-19 Patients

Article Link

Year:

2023

Characterization of Immunogenicity and Safety of COVID-19 mRNA-1273 in HIV-Positive Italian Patients with Hemophilia: A Prospective Single-Center Cohort Study

Article Link

Year:

2023

International Council for Standardization in Haematology recommendations for laboratory measurement of factor VIII and FIX type I inhibitors

Article Link

Year:

2023

Genetic Variants Identified by Whole Exome Sequencing in a Large Italian Family with High Plasma Levels of Factor VIII and Von Willebrand Factor

Article Link

Year:

2023

Psychological and cognitive factors involved in decision‐making process of haemophilia carriers in reproductive choices

Article Link

Year:

2023

Reply to “Comment on: A comparative study in type 2 von Willebrand disease patients using four different platelet-dependent von Willebrand factor assays”

Article Link

Year:

2023

Laboratory Diagnosis of Antiphospholipid Syndrome in Anticoagulated Patients

Article Link

Year:

2023

Diagnostic utility of bleeding assessment tools in congenital fibrinogen deficiencies

Article Link

Year:

2023

A comparative study in patients with type 2 von Willebrand disease using 4 different platelet-dependent von Willebrand factor assays

Article Link

Year:

2023

Collaborators8

Guy Young

UNITED STATES

View Details

Roberta Gualtierotti

Associate Professor

Università degli Studi di Torino

ITALY

View Details

Massimo Cugno

University of Milan

ITALY

View Details

Miguel Escobar

Professor (Tenure)

The University of Texas MD Anderson Cancer Center

UNITED STATES

View Details

LUCA FABRIS

Yale University

UNITED STATES

View Details

Adriano De Santis

Professor

Università degli Studi di Roma La Sapienza

ITALY

View Details

Frank Leebeek

Erasmus University Rotterdam

NETHERLANDS

View Details

Jeroen Eikenboom

Leiden University Medical Center

NETHERLANDS

View Details

How do I reach out?

Continue in dashboard